Reactive oxygen species‐regulating strategies based on nanomaterials for disease treatment

C Zhang, X Wang, J Du, Z Gu, Y Zhao - Advanced Science, 2021 - Wiley Online Library
Reactive oxygen species (ROS) play an essential role in physiological and pathological
processes. Studies on the regulation of ROS for disease treatments have caused wide …

Organelle-level precision with next-generation targeting technologies

A Saminathan, M Zajac, P Anees… - Nature Reviews Materials, 2022 - nature.com
Intracellular organelles are subsystems within a cell, whose activity and chemical
composition reflect the metabolic state of live cells. Alterations in cellular homeostasis …

Star polymers

JM Ren, TG McKenzie, Q Fu, EHH Wong, J Xu… - Chemical …, 2016 - ACS Publications
Recent advances in controlled/living polymerization techniques and highly efficient coupling
chemistries have enabled the facile synthesis of complex polymer architectures with …

Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics

S Marrache, S Dhar - … of the National Academy of Sciences, 2012 - National Acad Sciences
Mitochondrial dysfunctions cause numerous human disorders. A platform technology based
on biodegradable polymers for carrying bioactive molecules to the mitochondrial matrix …

[HTML][HTML] Targeting mitochondrial dysfunction and oxidative stress in activated microglia using dendrimer-based therapeutics

A Sharma, K Liaw, R Sharma, Z Zhang, S Kannan… - Theranostics, 2018 - ncbi.nlm.nih.gov
Mitochondrial oxidative stress is associated with many neurodegenerative diseases, such as
traumatic brain injury (TBI). Targeted delivery of antioxidants to mitochondria has failed to …

Design of polymeric carriers for intracellular peptide delivery in oncology applications

S Lv, M Sylvestre, AN Prossnitz, LF Yang… - Chemical …, 2021 - ACS Publications
In recent decades, peptides, which can possess high potency, excellent selectivity, and low
toxicity, have emerged as promising therapeutics for cancer applications. Combined with an …

Future of nanotherapeutics: Targeting the cellular sub-organelles

X Ma, N Gong, L Zhong, J Sun, XJ Liang - Biomaterials, 2016 - Elsevier
Many diseases originate from alterations at nanoscale levels. Precise drug delivery should
be achieved not only at cell level, but also at organelle level to achieve maximum …

[HTML][HTML] Nanopreparations for mitochondria targeting drug delivery system: current strategies and future prospective

Z Wang, W Guo, X Kuang, S Hou, H Liu - asian journal of pharmaceutical …, 2017 - Elsevier
Mitochondria are a novel and promising therapeutic target for diagnosis, treatment and
prevention of a lot of human diseases such as cancer, metabolic diseases and …

Targeted nanoparticles in mitochondrial medicine

RK Pathak, N Kolishetti, S Dhar - … Reviews: Nanomedicine and …, 2015 - Wiley Online Library
Mitochondria, the so‐called 'energy factory of cells' not only produce energy but also
contribute immensely in cellular mortality management. Mitochondrial dysfunctions result in …

Miktoarm star polymers: Branched architectures in drug delivery

V Lotocki, A Kakkar - Pharmaceutics, 2020 - mdpi.com
Delivering active pharmaceutical agents to disease sites using soft polymeric nanoparticles
continues to be a topical area of research. It is becoming increasingly evident that the …